共 23 条
Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system
被引:0
作者:
Singh, Robel
[1
]
Soni, Pawan
[2
]
Kumar, Davinder
[1
]
Aggarwal, Navidha
[3
]
Chopra, Hitesh
[4
]
Kumar, Virender
[1
]
机构:
[1] Univ Hlth Sci Rohtak, Coll Pharm, PGIMS, Pt BD Sharma, Rohtak 124001, India
[2] Govt India, Minist Hlth & Family Welf, Indian Pharmacopoeia Commiss, Ghaziabad, India
[3] Maharishi Markandeshwar Deemed Univ, MM Coll Pharm, Mullana 133207, Ambala, India
[4] Saveetha Inst Med & Tech Sci, Saveetha Sch Engn, Dept Biosci, Chennai 602105, Tamil Nadu, India
关键词:
alopecia areata;
auto-immune disorder;
clobetasol propionate;
exuberate;
Injectable modalities;
nanoparticulate drug delivery;
nonscarring;
systemic illness;
CLOBETASOL PROPIONATE 0.05-PERCENT;
TOPICAL MINOXIDIL;
LIPID NANOPARTICLES;
DRUG-DELIVERY;
HAIR FOLLICLE;
DERMAL DELIVERY;
DOUBLE-BLIND;
THERAPY;
PREVALENCE;
EFFICACY;
D O I:
10.4155/tde-2023-0071
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Alopecia areata (AA) is a kind of alopecia that affects hair follicles and nails. It typically comes with round patches and is a type of nonscarring hair loss. Various therapies are accessible for the management and treatment of AA, including topical, systemic and injectable modalities. It is a very complex type of autoimmune disease and is identified as round patches of hair loss and may occur at any age. This review paper highlights the epidemiology, clinical features, pathogenesis and new treatment options for AA, with a specific emphasis on nanoparticulate drug-delivery systems. By exploring these innovative treatment approaches, researchers aim to enhance the effectiveness and targeted delivery of therapeutic agents, ultimately improving outcomes for individuals living with AA.
引用
收藏
页码:193 / 210
页数:18
相关论文
共 23 条